Summary
HLA phenotypes and haplotypes in relation to organ-specific autoantibody responses were studied in 82 Japanese patients with Type 1 (insulin-dependent) diabetes. HLA-DRw9 antigen and HLA phenotype of DRw9/X (X: not DR4) were increased in patients with organ-specific autoantibodies other than islet cell antibody (CP<0.02, RR=4.02 and p<0.05, RR=2.30, respectively); whereas HLA-DR4 antigen and HLA phenotype of DR4/X (X: not DRw9) were increased in those without the autoantibodies (CP<0.001, RR=3.95 and p<0.01, RR=2.46, respectively). HLA haplotype of Bw61-DRw9 was increased in patients with the autoantibodies (p<0.005, RR=4.94), and HLA haplotype of Bw54-DR4 was increased in those without the autoantibodies (p<0.001, RR=5.52). The relative risk of HLA-DR4/DRw9 was the highest among all HLA-DR phenotypes or genotypes in patients either with or without the autoantibodies. No association was, however, found between the incidence of islet cell antibody and HLA-DR phenotypes. These findings suggest that Type 1 diabetes among Japanese is immunogenetically heterogeneous as is Type 1 diabetes among Caucasians; and the differences in HLA-association of Type 1 diabetes among ethnic groups might give a clue to understanding of a role of HLA-antigens in the development of Type 1 diabetes.
Article PDF
Similar content being viewed by others
References
Irvine WJ, McCallum CJ, Gray RS, Campbell CJ, Duncan LJP, Farquhar JW, Vaughan H, Morris PJ (1977) Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type. Diabetes 26: 138–147
Bottazzo GF, Cudworth AG, Moul DJ, Doniach D, Festenstein H (1978) Evidence for a primary autoimmune type of diabetes mellitus. Br Med J 2: 1253–1255
Rotter JI (1981) The modes of inheritance of insulin-dependent diabetes mellitus or the genetics of IDDM, no longer a nightmare but still a headache. Am J Hum Genet 33: 835–851
Eberhardt MS, Wagener DK, Orchard TJ, LaPorte RE, Cavender DE, Rabin BS, Atchison RW, Kuller LH, Drash AL, Becker DJ (1985) HLA heterogeneity of insulin-dependent diabetes mellitus at diagnosis. The Pittsburgh IDDM study. Diabetes 34: 1247–1252
Barbosa J, Chavers B, Dunsworth T, Michael A (1982) Islet cell antibodies and histocompatibility antigens (HLA) in insulin-dependent diabetics and their first-degree relatives. Diabetes 31: 585–588
Ginsberg-Fellner F, Dobersen MJ, Witt ME, Rayfield EJ, Rubinstein P, Notkins AL (1982) HLA antigen, cytoplasmic islet cell antibodies, and carbohydrate tolerance in families of children with insulin-dependent diabetes mellitus. Diabetes 31: 292–298
Winearls BC, Bodmer JG, Bodmer WF, Bottazzo GF, MaNally J, Mann JI, Thorogood M, Smith MA, Baum JD (1984) A family study of the association between insulin dependent diabetes, autoantibodies and the HLA system. Tissue Antigens 24: 234–246
Hedderich U, Winkler G, Goldmann S, Scherbaum WA, Pfeiffer EF (1986) Polyendocrine autoimmunity and HLA DR-types in children with Type 1 (insulin-dependent) diabetes of long duration. Diabetologia 29: 547A
Kitagawa T, Fujita H, Hibi I, Aagenaes Ø, Laron Z, LaPorte RE, Tajima N, Drash AL (1984) A comparative study on the epidemiology of IDDM between Japan, Norway, Israel and the United States. Acta Paediatr Jpn 26: 275–281
Wakisaka A, Aizawa M, Matsuura N, Nakagawa S, Nakayama E, Itakura K, Okuno A, Wagatsuma Y (1976) HLA and juvenile diabetes mellitus in the Japanese. Lancet II: 970
Kawa A, Nakazawa M, Sakaguchi S, Nakamura S, Kono Y, Hazeki H, Kanehisa T (1977) HLA system in Japanese patients with diabetes mellitus. Diabetes 26: 591–595
Sasazuki T, Kohno Y, Iwamoto I, Kosaka K, Okimoto K, Maruyama H, Ishiba S, Konishi J, Takada Y, Naito S (1978) HLA and Graves' disease or diabetes mellitus in Japan. N Engl J Med 298: 630–631
Sakurami T, Ueno Y, Nagaoka K, Kuno S, Iwaki Y, Park MS, Terasaki PI (1982) HLA-DR specifications in Japanese with juvenile-onset insulin-dependent diabetes mellitus. Diabetes 31: 105–106
Kobayashi T, Sugimoto T, Itoh T, Kosaka K, Tanaka T, Suwa S, Sato K, Tsuji K (1986) The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method. Diabetes 35: 335–340
Terasaki PI (1970) Cytotoxicity technique. In: Brand DR, Ray JG (eds) Manual of tissue typing techniques. National Institutes of Health, Bethesda MD, pp 42–45
Fujii Y, Juji T, Kaibara N (1983) Family study of HLA-A, B, C and DR in Japanese. Jpn J Transplant 18: 189–203
Boitard C, Bonifacio E, Bottazzo GF, Gleichmann H, Molenaar J (1988) Immunology and diabetes workshops: report on the third international (stage 3) workshop on standardisation of cytoplasmic islet cell antibodies. Diabetologia 31: 451–452
Svejgaard A, Platz P, Ryder LP (1980) Joint report. Insulin-dependent diabetes mellitus. In: Terasaki PI (ed) Histocompatibility testing 1980. Regnets of University of California, Los Angeles, CA, pp 638–656
Platz P, Jakobsen BK, Morling N, Ryder LP, Svejgaard A, Thomsen M, Christy M, Kromann H, Benn J, Nerup J, Green A, Hauge M (1981) HLA-D and DR antigens in genetic analysis of insulin-dependent diabetes mellitus. Diabetologia 21: 108–115
Wolf E, Spencer KM, Cudworth AG (1983) The genetic susceptibility to Type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association. Diabetologia 24: 224–230
Kida K, Mimura G (1987) Immunogenetic bases for insulin-dependent diabetes mellitus. In: Japan Diabetic Society (ed) Progress in diabetology 1987. Shindan-to-Chiryo-sha, Tokyo, pp 202–210
Bertrams J, Baur MP (1984) Disease reports, insulin-dependent diabetes mellitus. In: Albert ED, Baur MP, Mayr WR (eds) Histocompatibility testing 1984. Report on the Ninth International Histocompatibility workshop and Conference. Springer, Berlin Heidelberg New York, pp 348–358
Hawkins BR, Lam KSL, Ma JTC, Low LCK, Cheung PT, Serjeantson SW, Yeung RTT (1987) Strong association of HLA-DR3/DRw9 heterozygosity with early-onset insulin-dependent diabetes mellitus in Chinese. Diabetes 36: 1297–1300
Compston DAS, Vincent A, Newsom-Davis J, Batchelor JR (1980) Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 103: 579–601
Lee TD, Zhao TM, Bu KJ, Lu CZ, O'Donnell M, Sandler SG (1984) Association of HLA-DR4 with myasthenia gravis in the Chinese. Tissue Antigens 23: 127–129
Kida K, Hayashi M, Yamada I, Matsuda H, Yoshinaga J, Takami S, Yashiki S, Sonoda S (1987) Heterogeneity in myasthenia gravis: HLA phenotypes and autoantibody responses in ocular and generalized types. Ann Neurol 21: 274–278
Kohno T, Tsunetoshi Y, Ishikawa E (1988) Existence of anti-thyroglobulin IgG in healthy subjects. Biochem Biophys Res Comm 155: 224–229
Rotter JI, Anderson CE, Rubin R, Congleton JE, Terasaki PI, Rimoin DL (1983) HLA genotypic study of insulin-dependent diabetes. The excess of DR3/DR4 heterozygotes allows rejection of the recessive hypothesis. Diabetes 32: 169–174
Owerbach D, Lernmark Å, Platz P, Ryder LP, Rask L, Peterson PA, Ludvigsson J (1983) HLA-D region β-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals. Nature 303: 815–817
Cohen-Haguenauer O, Robbins E, Massart C, Busson M, Deschamps I, Hors J, Lalouel JM, Dausset J, Cohen D (1985) A systematic study of HLA class II-β DNA restriction fragments in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 82: 3335–3339
Böhme J, Carlsson B, Wallin J, Möller E, Persson B, Peterson PA, Rask L (1986) Only one DQ-β restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J Immunol 137: 941–947
Michelsen B, Lernmark A (1987) Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ. J Clin Invest 79: 1144–1152
Todd JA, Bell JI, McDevitt HO (1987) HLA-DQ β gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599–604
Nepom BS, Schwarz D, Palmer JP, Nepom GT (1987) Transcomplementation of HLA genes in IDDM. HLA-DQ α- and β-chain produce hybrid molecules in DR 3/4 heterozygotes. Diabetes 36: 114–117
Dausset J, Cohen D (1984) HLA at the gene level. In: Albert ED, Baur MP, Mayer WR (ed) Histocompatibility testing 1984. Springer, Berlin Heidelberg New York, pp 22–28
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kida, K., Mimura, G., Kobayashi, T. et al. Immunogenetic heterogeneity in Type 1 (insulin-dependent) diabetes among Japanese — HLA antigens and organ-specific autoantibodies. Diabetologia 32, 34–39 (1989). https://doi.org/10.1007/BF00265401
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00265401